{"transactions":[{"id":698598,"issuer":{"id":5946,"kind":"organization","name":"ProQR Therapeutics N.V."},"owners":[{"id":27112,"kind":"person","name":"de Boer Daniel Anton","position":1,"cik":"0002117546","reported_name":"de Boer Daniel Anton","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-03T20:01:11.000Z","date":"2026-07-31","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":1.7698,"value":353960.0,"ownership":{"direct":true},"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001104659-26-089780","document":"tm2622051-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612940/000110465926089780/tm2622051-1_4seq1.xml","form_type":"4"}},{"id":705097,"issuer":{"id":5946,"kind":"organization","name":"ProQR Therapeutics N.V."},"owners":[{"id":29272,"kind":"person","name":"Filius Bart","position":1,"cik":"0002115417","reported_name":"Filius Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-21T12:00:17.000Z","date":"2026-07-17","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":1.7195,"value":257925.0,"ownership":{"direct":true},"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001104659-26-085234","document":"tm2620903-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612940/000110465926085234/tm2620903-1_4seq1.xml","form_type":"4"}},{"id":710454,"issuer":{"id":5946,"kind":"organization","name":"ProQR Therapeutics N.V."},"owners":[{"id":27112,"kind":"person","name":"de Boer Daniel Anton","position":1,"cik":"0002117546","reported_name":"de Boer Daniel Anton","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-13T12:00:05.000Z","date":"2026-07-09","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":1.74,"value":261000.0,"ownership":{"direct":true},"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001104659-26-082890","document":"tm2620241-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612940/000110465926082890/tm2620241-1_4seq1.xml","form_type":"4"}},{"id":712422,"issuer":{"id":5946,"kind":"organization","name":"ProQR Therapeutics N.V."},"owners":[{"id":27112,"kind":"person","name":"de Boer Daniel Anton","position":1,"cik":"0002117546","reported_name":"de Boer Daniel Anton","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-08T18:55:28.000Z","date":"2026-07-07","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":1.59,"value":238500.0,"ownership":{"direct":true},"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001104659-26-081762","document":"tm2620064-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612940/000110465926081762/tm2620064-1_4seq1.xml","form_type":"4"}},{"id":722581,"issuer":{"id":5946,"kind":"organization","name":"ProQR Therapeutics N.V."},"owners":[{"id":34410,"kind":"person","name":"Hinsch Gylvin Lykke","position":1,"cik":"0002135139","reported_name":"Hinsch Gylvin Lykke","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-30T20:02:38.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":14595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The price reported in Column 2 is based upon the closing market price of the Issuer's ordinary shares on June 1, 2026, as determined pursuant to the Issuer's Board Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable on June 2, 2027, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":14595,"derivative":{"exercise_price":1.42,"expiration_date":"2036-06-01","underlying":"Ordinary Shares","underlying_shares":14595},"source":{"system":"sec-edgar","filing":"0001104659-26-079319","document":"tm2619428-2_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612940/000110465926079319/tm2619428-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-06-03"}},{"id":722576,"issuer":{"id":5946,"kind":"organization","name":"ProQR Therapeutics N.V."},"owners":[{"id":29272,"kind":"person","name":"Filius Bart","position":1,"cik":"0002115417","reported_name":"Filius Bart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-30T20:01:13.000Z","date":"2026-06-26","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":1.54,"value":231000.0,"ownership":{"direct":true},"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001104659-26-079316","document":"tm2619428-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612940/000110465926079316/tm2619428-1_4seq1.xml","form_type":"4"}},{"id":750854,"issuer":{"id":5946,"kind":"organization","name":"ProQR Therapeutics N.V."},"owners":[{"id":34410,"kind":"person","name":"Hinsch Gylvin Lykke","position":1,"cik":"0002135139","reported_name":"Hinsch Gylvin Lykke","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-03T20:01:09.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":14495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The price reported in Column 2 is based upon the closing market price of the Issuer's ordinary shares on June 1, 2026, as determined pursuant to the Issuer's Board Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable on June 2, 2027, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":14495,"derivative":{"exercise_price":1.42,"expiration_date":"2036-06-01","underlying":"Ordinary Shares","underlying_shares":14495},"source":{"system":"sec-edgar","filing":"0001104659-26-070090","document":"tm2616802-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612940/000110465926070090/tm2616802-1_4seq1.xml","form_type":"4"}}]}